Item Type | Name |
Concept
|
Satellite Cells, Skeletal Muscle
|
Concept
|
Muscle, Skeletal
|
Academic Article
|
TNF inhibits Notch-1 in skeletal muscle cells by Ezh2 and DNA methylation mediated repression: implications in duchenne muscular dystrophy.
|
Academic Article
|
MyoD Regulates Skeletal Muscle Oxidative Metabolism Cooperatively with Alternative NF-?B.
|
Academic Article
|
An NF-?B--EphrinA5-Dependent Communication between NG2(+) Interstitial Cells and Myoblasts Promotes Muscle Growth in Neonates.
|
Academic Article
|
NF-?B-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia.
|
Academic Article
|
IKKa and alternative NF-?B regulate PGC-1? to promote oxidative muscle metabolism.
|
Academic Article
|
NF-?B negatively impacts the myogenic potential of muscle-derived stem cells.
|
Academic Article
|
NF-?B signaling in skeletal muscle health and disease.
|
Academic Article
|
NF-kappaB signaling: a tale of two pathways in skeletal myogenesis.
|
Academic Article
|
NF-kappaB functions in stromal fibroblasts to regulate early postnatal muscle development.
|
Academic Article
|
The RelA/p65 subunit of NF-kappaB specifically regulates cyclin D1 protein stability: implications for cell cycle withdrawal and skeletal myogenesis.
|
Academic Article
|
Skeletal muscle diseases, inflammation, and NF-kappaB signaling: insights and opportunities for therapeutic intervention.
|
Academic Article
|
IKK/NF-kappaB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis.
|
Academic Article
|
Thrombin causes a marked delay in skeletal myogenesis that correlates with the delayed expression of myogenin and p21CIP1/WAF1.
|
Academic Article
|
Regulation of skeletal muscle oxidative phenotype by classical NF-?B signalling.
|
Academic Article
|
Reining in nuclear factor-kappaB in skeletal muscle disorders.
|
Academic Article
|
Detection of NF-?B activity in skeletal muscle cells by electrophoretic mobility shift analysis.
|
Academic Article
|
Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo.
|
Academic Article
|
Systemic delivery of NEMO binding domain/IKK? inhibitory peptide to young mdx mice improves dystrophic skeletal muscle histopathology.
|
Academic Article
|
Inhibition of the IKK/NF-?B pathway by AAV gene transfer improves muscle regeneration in older mdx mice.
|
Academic Article
|
Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy.
|
Academic Article
|
Signaling pathways weigh in on decisions to make or break skeletal muscle.
|
Academic Article
|
Tumor necrosis factor-regulated biphasic activation of NF-kappa B is required for cytokine-induced loss of skeletal muscle gene products.
|
Academic Article
|
NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia.
|
Academic Article
|
NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.
|
Academic Article
|
Cancer cachexia is regulated by selective targeting of skeletal muscle gene products.
|
Academic Article
|
Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia.
|
Academic Article
|
The molecular mechanisms of skeletal muscle wasting: implications for therapy.
|
Academic Article
|
Cancer cachexia syndrome in head and neck cancer patients: Part II. Pathophysiology.
|
Academic Article
|
Immunocompetent murine model of cancer cachexia for head and neck squamous cell carcinoma.
|
Academic Article
|
Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia.
|
Academic Article
|
DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo.
|
Academic Article
|
STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia.
|
Academic Article
|
Making muscles grow by g protein-coupled receptor signaling.
|
Academic Article
|
Loss of miR-29 in myoblasts contributes to dystrophic muscle pathogenesis.
|
Academic Article
|
Report on the Myomatrix Conference April 22-24, 2012, University of Nevada, Reno, Nevada, USA.
|
Academic Article
|
Mechanisms for maintaining muscle.
|
Academic Article
|
Mechanisms of impaired differentiation in rhabdomyosarcoma.
|
Academic Article
|
Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7.
|
Academic Article
|
Metabolomic profiling reveals severe skeletal muscle group-specific perturbations of metabolism in aged FBN rats.
|
Academic Article
|
Inflammation based regulation of cancer cachexia.
|
Academic Article
|
Evaluating potential biomarkers of cachexia and survival in skeletal muscle of upper gastrointestinal cancer patients.
|
Academic Article
|
Mineralocorticoid receptors are present in skeletal muscle and represent a potential therapeutic target.
|
Academic Article
|
Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.
|
Academic Article
|
Inflammation induced loss of skeletal muscle.
|
Academic Article
|
Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia.
|
Academic Article
|
A TGF-? pathway associated with cancer cachexia.
|
Academic Article
|
Mechano-signalling pathways in an experimental intensive critical illness myopathy model.
|
Academic Article
|
Analysis of Aerobic Respiration in Intact Skeletal Muscle Tissue by Microplate-Based Respirometry.
|
Academic Article
|
Dual Inhibition of MEK and PI3K/Akt Rescues Cancer Cachexia through both Tumor-Extrinsic and -Intrinsic Activities.
|
Academic Article
|
Dysregulated Myogenesis in Rhabdomyosarcoma.
|
Academic Article
|
Modeling Human Cancer-induced Cachexia.
|
Academic Article
|
Extracellular vesicles derived from tumour cells as a trigger of energy crisis in the skeletal muscle.
|
Academic Article
|
Cancer cachexia: involvement of an expanding macroenvironment.
|